Zobrazeno 1 - 10
of 196
pro vyhledávání: '"Melissa A. Geller"'
Autor:
Rachel I. Vogel, Ashley E. Stenzel, Heewon Lee, DeVon Hunter-Schlichting, Erin Wesley, Locke D. Uppendahl, Melissa A. Geller, Heather H. Nelson
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-7 (2023)
Abstract Purpose One of the most frequently reported effects of cancer and its treatments is cancer-related cognitive impairment (CRCI). Viral infections may affect inflammation and immune function and therefore may influence patient symptoms, includ
Externí odkaz:
https://doaj.org/article/861a5edc997a47b4bdef0eae8010cd5d
Publikováno v:
Women's Health Reports, Vol 2, Iss 1, Pp 78-84 (2021)
Background: The objective of the study was to compare family planning and infertility among female and male gynecologic oncologists in the United States Methods: This cross-sectional multiple choice survey was administered to the Society of Gynecolog
Externí odkaz:
https://doaj.org/article/1f7b9c7669cd48f4b0686586548a3115
Autor:
Jianbo Yang, Qianjin Liao, Matthew Price, Branden Moriarity, Natalie Wolf, Martin Felices, Jeffrey S. Miller, Melissa A. Geller, Laura Bendzick, Rachel Hopps, Timothy K. Starr, Christine H. O'Connor, Sarah Tarullo, Andrew C. Nelson, Eva Turley, Jing Wang, James B. McCarthy
Publikováno v:
Translational Oncology, Vol 16, Iss , Pp 101318- (2022)
Epithelial ovarian cancer (EOC) is a highly heterogeneous disease encompassing several distinct molecular subtypes and clinical entities. Despite the initial success of surgical debulking and adjuvant chemotherapy, recurrence with chemotherapy resist
Externí odkaz:
https://doaj.org/article/652d0641e7444755a9bac2d67231898f
Autor:
Pamela C. Rosato, Sathi Wijeyesinghe, J. Michael Stolley, Christine E. Nelson, Rachel L. Davis, Luke S. Manlove, Christopher A. Pennell, Bruce R. Blazar, Clark C. Chen, Melissa A. Geller, Vaiva Vezys, David Masopust
Publikováno v:
Nature Communications, Vol 10, Iss 1, Pp 1-9 (2019)
The immunosuppressive tumor environment and the lack of functional anti-tumor immunity are major limiting factors in immunotherapy. Here the authors show that human and mouse tumors are infiltrated by virus-specific memory T cells, which can be harne
Externí odkaz:
https://doaj.org/article/5f068cea4ece4349a43cb5cd50da3600
Autor:
Kristin L. M. Boylan, Ashley Petersen, Timothy K. Starr, Xuan Pu, Melissa A. Geller, Robert C. Bast, Karen H. Lu, Ugo Cavallaro, Denise C. Connolly, Kevin M. Elias, Daniel W. Cramer, Tanja Pejovic, Amy P. N. Skubitz
Publikováno v:
Cancers, Vol 14, Iss 13, p 3077 (2022)
Background: Individual serum biomarkers are neither adequately sensitive nor specific for use in screening the general population for ovarian cancer. The purpose of this study was to develop a multiprotein classifier to detect the early stages of ova
Externí odkaz:
https://doaj.org/article/d1c5d19fb2db4e15a2b5743c09ad3c3b
Autor:
Rachel Isaksson Vogel, Kristin Niendorf, Heewon Lee, Sue Petzel, Hee Yun Lee, Melissa A. Geller
Publikováno v:
Hereditary Cancer in Clinical Practice, Vol 16, Iss 1, Pp 1-7 (2018)
Abstract Background National guidelines recommend genetic counseling for all ovarian cancer patients because up to 20% of ovarian cancers are thought to be due to hereditary cancer syndromes and effective cancer screening and prevention options exist
Externí odkaz:
https://doaj.org/article/a5e53352edbd4f00a4229d5fcbc22285
Autor:
Daniel A. Vallera, Felix Oh, Behiye Kodal, Peter Hinderlie, Melissa A. Geller, Jeffrey S. Miller, Martin Felices
Publikováno v:
Cancers, Vol 13, Iss 16, p 3994 (2021)
Clinical studies validated antibodies directed against HER2, trastuzumab, and pertuzumab, as useful methodology to target breast cancer cases where HER2 is expressed. The hope was that HER2 targeting using these antibodies in ovarian cancer patients
Externí odkaz:
https://doaj.org/article/8b95513dab3844e0b8a382fef0abdb4d
Autor:
Kristin L. M. Boylan, Kate Geschwind, Joseph S. Koopmeiners, Melissa A. Geller, Timothy K. Starr, Amy P. N. Skubitz
Publikováno v:
Clinical Proteomics, Vol 14, Iss 1, Pp 1-21 (2017)
Abstract Background Currently, there are no FDA approved screening tools for detecting early stage ovarian cancer in the general population. Development of a biomarker-based assay for early detection would significantly improve the survival of ovaria
Externí odkaz:
https://doaj.org/article/1add60ae1fbf46658bf4960d9820087b
Autor:
Daniel A. Vallera, Soldano Ferrone, Behiye Kodal, Peter Hinderlie, Laura Bendzick, Brianna Ettestad, Caroline Hallstrom, Nicholas A. Zorko, Arpit Rao, Naomi Fujioka, Charles J. Ryan, Melissa A. Geller, Jeffrey S. Miller, Martin Felices
Publikováno v:
Cancers, Vol 12, Iss 9, p 2659 (2020)
We improved the bispecific antibody platform that primarily engages natural killer (NK) cells to kill cancer cells through antibody-dependent cellular cytotoxicity (ADCC) by adding IL-15 as a crosslinker that expands and self-sustains the effector NK
Externí odkaz:
https://doaj.org/article/e5b5e5dd048c4eeab22547eee35c74ef
Publikováno v:
Frontiers in Immunology, Vol 8 (2018)
Harnessing the immune system has proven an effective therapy in treating malignancies. Since the discovery of natural killer (NK) cells, strategies aimed to manipulate and augment their effector function against cancer have been the subject of intens
Externí odkaz:
https://doaj.org/article/f06108c8a90b43969d66e711975d5177